2012 - Pulmonary inflammation in paediatric respiratory disease

Lung diseases that start during infancy and childhood have common features and fundamental differences. The objective of this seminar was to look at airway inflammation as a cause of and a consequence of four specific lung diseases that start during childhood and can have long-term consequences up to and through adulthood.

2012 - Pulmonary inflammation in paediatric respiratory disease

2024 - Sleep apnea and its consequences: from animal models to precision medicine

2023 - In Vitro Diagnostic (IVD) tests to combat antimicrobial resistance in community-acquired low-respiratory tract infections (CA-LRTI)

2019 - New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

Case report: An infant with acute severe bronchiolitis

G. Cangiano (Rome, Italy)

Slides

Accompanying documents

Case report: Early airway inflammation in a CF child

C. Abbas (Bern, Switzerland)

Slides

Accompanying documents

Genetic studies in paediatric interstitial lung disease

N. Nathan (Paris, France)

Slides

Accompanying documents

Rational for the new term paediatric diffuse parenchymal lung disease (DPLD)

A. Clément (Paris, France)

Slides

Accompanying documents

Update on basic research on airway inflammation in DPLD

B. Crestani (Paris, France)

Slides

Accompanying documents

Case report: A term newborn with mild respiratory distress

E. Mueller (Wien, Austria)

Slides

Accompanying documents

Update on the impact of inflammation/colonisation/infection of bacterias and viruses knowledge gaps

N. Regamey (Bern, Switzerland)

Slides

Accompanying documents

Case report: a CF child with severe airway inflammation

S. Yammine (Bern, Switzerland)

Slides

Accompanying documents

Role of altered immune response in CF and implication for antiinflammatory therapies

H. Grasemann (Toronto, On, Canada)

Slides

Accompanying documents

Role of CF ion transport defect in airway inflammation and implication for antiinflammatory therapies

M. Mall (Heidelberg, Germany)

Slides

Accompanying documents

Update on anti-inflammatory therapy in asthma

F. De Benedictis (Ancona, Italy)

Slides

Accompanying documents

The innate immune system of the pathogenesis of vital bronchiolitis

L. Bont (Utrecht, Netherlands)

Slides

Accompanying documents

Update on inflammatory mechanisms and monitoring of asthma-knowledge gaps

K. Lodrup Carlsen (Oslo, Norway)

Assembly Symposium

Accompanying documents

Case report: A child with non-allergic asthma

J. Konradsen (Stockholm, Sweden)

Slides

Airway remodeling in asthma

S. Saglani (London, United Kingdom)

Slides

Accompanying documents

Update on basic research on airway inflammation in asthma

H. Smits (Leiden , Netherlands)

Slides

Accompanying documents

Case report: a child with allergic asthma

T. Klok (Zwolle, Netherlands)

Slides

Accompanying documents

The most important knowledge gaps

F. Midulla (Rome, Italy)

Slides

Accompanying documents

Factors that influence bronchiolitis severity

K-H. Carlsen (Oslo, Norway)

Slides

Accompanying documents

Bronchiolitis, wheezing bronchitis and asthma: exploring environmental and genetic factors

J. Schwarze (Edinburgh, United Kingdom)

Assembly Symposium

Accompanying documents

The impact of airway inflammation in DPLD: knowledge gaps

E. Eber (Graz, Austria)

Slides

Accompanying documents

CDN Connection Issue

2012 - Pulmonary inflammation in paediatric respiratory disease

2012 - Pulmonary inflammation in paediatric respiratory disease

#{title}